The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial.
Maryam KhazdouzNaser Ebrahimi DaryaniMakan CheraghpourForoogh AlborziMotahareh HasaniShaghayegh Baradaran GhavamiFarzad ShidfarPublished in: European journal of nutrition (2023)
IRCT20091114002709N51; 2020-04-13.
Keyphrases
- disease activity
- double blind
- placebo controlled
- ulcerative colitis
- clinical trial
- rheumatoid arthritis
- systemic lupus erythematosus
- phase ii
- rheumatoid arthritis patients
- ankylosing spondylitis
- phase iii
- study protocol
- juvenile idiopathic arthritis
- oxidative stress
- phase ii study
- open label
- squamous cell carcinoma
- randomized controlled trial